CLINICAL SEPSIS TRIALS

被引：2

作者：

ABRAHAM, E

机构：

来源：

CHEST | 1994年 / 105卷 / 03期

关键词：

D O I：

10.1378/chest.105.3_Supplement.53S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S53 / S55

页数：3

共 29 条

[1] [Anonymous], 1992, CRIT CARE MED, V20, P864
[2] A CRITICAL-EVALUATION OF NEW AGENTS FOR THE TREATMENT OF SEPSIS
BONE, RC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (12): : 1686 - 1691
[3] HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES
CALANDRA, T
GERAIN, J
HEUMANN, D
BAUMGARTNER, JD
GLAUSER, MP
[J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) : 23 - 29
[4] TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS
DAMAS, P
REUTER, A
GYSEN, P
DEMONTY, J
LAMY, M
FRANCHIMONT, P
[J]. CRITICAL CARE MEDICINE, 1989, 17 (10) : 975 - 978
[5] PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS
DEBETS, JMH
KAMPMEIJER, R
VANDERLINDEN, MPMH
BUURMAN, WA
VANDERLINDEN, CJ
[J]. CRITICAL CARE MEDICINE, 1989, 17 (06) : 489 - 494
[6] DINARELLO CA, 1991, BLOOD, V77, P1627
[7] PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS
DOFFERHOFF, ASM
BOM, VJJ
DEVRIESHOSPERS, HG
VANINGEN, J
VANDERMEER, J
HAZENBERG, BPC
MULDER, POM
WEITS, J
[J]. CRITICAL CARE MEDICINE, 1992, 20 (02) : 185 - 192
[8] INTERLEUKIN-1 RECEPTOR BLOCKADE IMPROVES SURVIVAL AND HEMODYNAMIC PERFORMANCE IN ESCHERICHIA-COLI SEPTIC SHOCK, BUT FAILS TO ALTER HOST RESPONSES TO SUBLETHAL ENDOTOXEMIA
FISCHER, E
MARANO, MA
VANZEE, KJ
ROCK, CS
HAWES, AS
THOMPSON, WA
DEFORGE, L
KENNEY, JS
REMICK, DG
BLOEDOW, DC
THOMPSON, RC
LOWRY, SF
MOLDAWER, LL
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) : 1551 - 1557
[9] INFLUENCE OF AN ANTITUMOR NECROSIS FACTOR MONOCLONAL-ANTIBODY ON CYTOKINE LEVELS IN PATIENTS WITH SEPSIS
FISHER, CJ
OPAL, SM
DHAINAUT, JF
STEPHENS, S
ZIMMERMAN, JL
NIGHTINGALE, P
HARRIS, SJ
SCHEIN, RMH
PANACEK, EA
VINCENT, JL
FOULKE, GE
WARREN, EL
GARRARD, C
PARK, G
BODMER, MW
COHEN, J
VANDERLINDEN, C
CROSS, AS
SADOFF, JC
GORECKI, J
DUBIN, HG
GARNER, C
KAYE, W
LANORE, JJ
MIRA, JP
ZIMMERMAN, J
DELLINGER, RP
TAYLOR, RW
DAHL, S
SHELLY, M
MORTIMER, A
EDWARDS, JD
KETT, DH
QUARTIN, A
PENA, MA
BAKKER, J
ALBERSON, TE
WALBY, W
RADCLIFFE, J
YOUNG, D
MCQUILLAM, P
BELLINGHAM, G
BURMAN, W
SADOFF, JS
YOUNG, L
[J]. CRITICAL CARE MEDICINE, 1993, 21 (03) : 318 - 327
[10] A CONTROLLED CLINICAL-TRIAL OF E5 MURINE MONOCLONAL IGM ANTIBODY TO ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS
GREENMAN, RL
SCHEIN, RMH
MARTIN, MA
WENZEL, RP
MACINTYRE, NR
EMMANUEL, G
CHMEL, H
KOHLER, RB
MCCARTHY, M
PLOUFFE, J
RUSSELL, JA
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (08): : 1097 - 1102

← 1 2 3 →